 |
인쇄하기
취소
|
Shinpoong, MMV launch Phase III clinical trials for anti-malaria drug
Shinpoong Pharm and the Medicines for Malaria Venture (MMV) are conducting the Phase III clinical trials for PYRAMAX, pyronaridine-artesunate, a new artemisinin-based combination treatment (ACT) for malaria.
The studies will involve over 3,000 children, adolescents, and adults in more than 12 countries where malaria is endemic.
Malaria experts from Asian and African countries are collabor...
The studies will involve over 3,000 children, adolescents, and adults in more than 12 countries where malaria is endemic.
Malaria experts from Asian and African countries are collabor...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.